Results 11 to 20 of about 33,202 (275)
Journal of Sleep Research, 2022 This article addresses the clinical presentation, diagnosis, pathophysiology and management of narcolepsy type 1 and 2, with a focus on recent findings. A low level of hypocretin‐1/orexin‐A in the cerebrospinal fluid is sufficient to diagnose narcolepsy ...
L. Barateau +3 more
semanticscholar +3 more sources
Narcolepsy Along with an Update [PDF]
Türk Uyku Tıbbı Dergisi, 2015 Narcolepsy is the most common primary hypersomnia, which is caused by loss of hypocretin neurons. Hypocretin in the neurohypothalamus is of crucial role in the maintenance of awakeness. Narcolepsy is characterized by hypnagogic/hypnopompic hallucinations,
Kutluhan Yilmaz
doaj +2 more sources
Narcolepsy Syndrome in a Patient with Multiple Sclerosis
Türk Uyku Tıbbı Dergisi, 2014 Narcolepsy syndrome is characterized by excessive daytime sleepiness with or without cataplexy. In addition to excessive daytime sleepiness and cataplexy, other symptoms related to REM-sleep such as disturbed night sleep, sleep paralysis and hypnopompic ...
Deniz Yerdelen +4 more
doaj +2 more sources
The Impact of Narcolepsy on Psychological Health and Role Behaviours: Negative Effects and Comparisons With Other Illness Groups [PDF]
, 2001 Adjustment to an illness can be conceptualised in terms of people's ability to adequately function in their life roles (eg worker, spouse, parent and friend).
Bruck, Dorothy, D Bruck
core +7 more sources
Neuropsychiatric Disease and Treatment, 2011 Gbolagade Sunmaila Akintomide1, Hugh Rickards21Department of Neuropsychiatry, University of Birmingham, 2Department of Neuropsychiatry, The Barberry, Edgbaston, Birmingham, UKAbstract: Narcolepsy is a lifelong sleep disorder characterized by a classic ...
Akintomide GS, Rickards H
doaj +2 more sources
A Case of Secondary Narcolepsy Presenting with Obstructive Sleep Apnea Symptoms [PDF]
Türk Uyku Tıbbı Dergisi, 2016 Obstructive sleep apnea syndrome (OSAS) and narcolepsy are two diseases causing excessive daytime sleepiness (EDS). As they are often confused, these two disorders can also coexist.
Sebahat Genç +4 more
doaj +2 more sources
Update on the treatment of narcolepsy: clinical efficacy of pitolisant
Nature and Science of Sleep, 2017 Michael W Calik1,2 1Department of Biobehavioral Health Science, 2Center for Narcolepsy, Sleep and Health Research, University of Illinois at Chicago, Chicago, IL, United States Abstract: Narcolepsy is a neurological disease that affects 1 in 2,000 ...
Calik MW
doaj +1 more source
Journal of Clinical Neurophysiology, 1990 Narcolepsy is a neurological condition with a prevalence of up to 1 per 1,000 that is characterized by irresistible bouts of sleep. Associated features include the pathological manifestations of rapid-eye-movement (REM) sleep: cataplexy, sleep paralysis, hypnagogic hallucinations, and abnormal sleep-onset REM periods and disturbed nocturnal sleep.
M M, Mitler +3 more
openaire +5 more sources
El sistema hipocretina / orexina en la fisiopatología de las hipersomnias de origen central [PDF]
, 2007 [spa] INTRODUCCIÓN. El sistema hipocretina/orexina es un sistema neurotransmisor hipotalámico con funciones promotoras de la vigilia. La narcolepsia, enfermedad caracterizada por una excesiva somnolencia diurna y manifestaciones anormales del sueño REM ...
Martínez Rodríguez, José Enrique
core +6 more sources
Prevalence and incidence of narcolepsy symptoms in the US general population
Sleep Medicine: X, 2023 Objective The objectives of this study are to evaluate the prevalence and incidence of Narcolepsy type 1 and type 2 and to determine the prevalence of narcolepsy diagnosis criteria in the US general population.
M. Ohayon, S. Duhoux, J. Grieco, M. Cote
semanticscholar +1 more source